ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BPMC Blueprint Medicines Corporation

86.82
-3.68 (-4.07%)
Mar 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 996,788
Bid Price 65.00
Ask Price 109.56
News -
Day High 91.67

Low
41.54

52 Week Range

High
101.00

Day Low 86.10
Company Name Stock Ticker Symbol Market Type
Blueprint Medicines Corporation BPMC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-3.68 -4.07% 86.82 20:00:00
Open Price Low Price High Price Close Price Prev Close
90.86 86.10 91.67 86.82 90.50
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
16,665 996,788 $ 89.61 $ 89,321,556 - 41.54 - 101.00
Last Trade Time Type Quantity Stock Price Currency
16:20:00 28 $ 86.82 USD

Blueprint Medicines (BPMC) Options Flow Summary

Overall Flow

Bullish

Net Premium

404k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Blueprint Medicines Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.31B 61.23M - 249.38M -506.98M -8.28 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Blueprint Medicines News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BPMC Message Board. Create One! See More Posts on BPMC Message Board See More Message Board Posts

Historical BPMC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week92.1292.8486.1089.77681,124-5.30-5.75%
1 Month88.98101.0080.4291.70950,046-2.16-2.43%
3 Months90.00101.0072.2486.41800,415-3.18-3.53%
6 Months50.40101.0043.8974.31796,25936.4272.26%
1 Year44.88101.0041.5465.71704,93841.9493.45%
3 Years104.58117.8637.8267.29640,129-17.76-16.98%
5 Years85.99125.6137.8271.65599,3750.830.97%

Blueprint Medicines Description

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

Your Recent History

Delayed Upgrade Clock